Ivosidenib(Tibsovo)

Another Nameivosidenib,Tibsovo,LuciVos,艾伏尼布,依维替尼

IndicationsIt is indicated for patients with susceptible isocitrate dehydrogenase-1 (IDH1) mutations confirmed by a test method approved by the FDA.